EcoDrugPlus

Aromatase

Ensembl ID : ENSATEG00000017392
Gene Symbol: LOC113174828
3 Cross references
252 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSATEG00000019731
Gene Symbol: LOC113170924
2 Cross references
191 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2

Ensembl ID : ENSATEG00000004088
Gene Symbol: LOC113148227
2 Cross references
186 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSATEG00000025034
Gene Symbol: AURKA
2 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSATEG00000001897
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSATEG00000014989
Gene Symbol: LOC113153311
3 Cross references
216 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSATEG00000026283
Gene Symbol: LOC113169892
2 Cross references
168 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSATEG00000022487
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

C-Abl Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSATEG00000018625
Gene Symbol: ABL1
2 Cross references
202 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 7b

Ensembl ID : ENSATEG00000004395
Gene Symbol: LOC113149207
3 Cross references
174 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSATEG00000015236
Gene Symbol: CACNA1C
1 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSATEG00000008330
Gene Symbol: CACNA1DA
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).